Cohort of Respiratory Failure Patients Treated for the First Time With Non-Invasive Ventilation at Home
NCT ID: NCT02346305
Last Updated: 2023-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2015-01-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators' purpose is that a better knowledge of NIV practices could improve both the quality to support patients at home and the efficacy of the treatment.
The main objective of this study is to analyze the clinical data justifying the prescription of NIV advice according respiratory disease. The secondary objectives are to study comorbidities, treatment failures, survival rate during the study period.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home Non-invasive Ventilation for Chronic Obstructive Pulmonary Disease Patients
NCT01526642
Monitoring of Patients With Chronic Respiratory Failure Treated With Non-invasive Home Ventilation: Contribution of New Monitoring Tools
NCT04872062
Installation of Non-invasive Ventilation at Home Using Telemedicine : a Pilot Study on Feasibility and Impact on Ventilation Compliance
NCT02103790
Home Non Invasive Ventilation (NIV) Treatment for COPD-patients After a NIV-treated Exacerbation
NCT01513655
Initiation of Non- Invasive Ventilation at Home Versus Hospital Among Patients With Overlap Syndrome
NCT02363413
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-invasive ventilation
Home NIV installation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patients, ≥ 18 years of age
* Without tracheotomy
* No evolutive cancer
* No significant psychiatric disease
* Possible medical monitoring
Exclusion Criteria
* Inability to understand rationale and/or consent form for study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudio RABEC, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire Dijon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU d'Angers
Angers, , France
CHU de Besançon
Besançon, , France
CH de Cannes
Cannes, , France
CHU de Dijon
Dijon, , France
Garches
Garches, , France
CHU de Grenoble
Grenoble, , France
CHD de la Réunion
La Réunion, , France
CHU de Lille
Lille, , France
CHU de Limoges
Limoges, , France
CHU de Nancy
Nancy, , France
AP-HP Pitié-Salpêtrière
Paris, , France
Hôpital Edouard Rist
Paris, , France
CHU de Rouen
Rouen, , France
CHU de Rouen
Rouen, , France
CHU de Strasbourg
Strasbourg, , France
CHU de Toulouse
Toulouse, , France
Hôpital Robert Schuman
Vantoux, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Frédéric GAGNADOUX, Pr
Role: primary
Frédéric CLAUDE, MD
Role: primary
Christophe PERRIN, MD
Role: primary
Hélène PRIGENT, MD
Role: primary
Jean-Louis PEPIN, Pr
Role: primary
Ziad RIDA, MD
Role: primary
Anne MALLART, MD
Role: primary
Boris MELLONI, Pr
Role: primary
François CHABOT, Pr
Role: primary
Jésus GONZALEZ, MD
Role: primary
Franck LAVERGNE, MD
Role: primary
Antoine CUVELIER, Pr
Role: primary
Jean-François MUIR, Pr
Role: primary
Romain KESSLER, Pr
Role: primary
Sandrine PONTIER, MD
Role: primary
Pierre CERVANTES, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014 - NIV - 14734
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.